What new treatments for polymyositis are being studied in clinical trials?

Suhail Kumar, MD
Biologic drugs including rituximab and tumor necrosis factor alpha (TNF) inhibitors are being further studied for treatment of polymyositis.  Interferon alfa-2a is also under investigation.
Dr. Mehmet Oz, MD
Cardiology (Cardiovascular Disease)
Scientists are studying various new approaches to treating polymyositis. For example, ongoing clinical trials are testing whether people with polymyositis benefit from the drug rituximab, which is usually used in treating cancer and rheumatoid arthritis. Researchers also know that a glitch in the way certain genes behave is associated with this disease. Developing medications that correct this problem could treat polymyositis.

Continue Learning about Polymyositis



Polymyositis affects skeletal muscles on both sides of the body, usually affected adults between 31 and 60 years old. People with polymyositis may also experience arthritis, shortness of breath, difficulty swallowing and speaking ...

and heart arrhythmias. Treatment options include medication, exercise, heat therapy, physical therapy, orthotics and assistive devices and rest.

Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.